Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Modalis Therapeutics Corporation ( (JP:4883) ) has provided an update.
Modalis Therapeutics Corporation has completed the pay-in procedures for issuing new shares as part of a restricted-stock-based remuneration plan for its subsidiary employees. This issuance involves 2,300 common shares at a price of 75 yen per share, reflecting the company’s commitment to incentivizing its workforce and potentially enhancing its operational efficiency.
More about Modalis Therapeutics Corporation
Modalis Therapeutics Corporation is a biotechnology company listed on the Tokyo Stock Exchange, focused on developing innovative therapeutic solutions. The company specializes in gene therapy technologies and aims to address unmet medical needs in the healthcare industry.
Average Trading Volume: 1,710,715
Technical Sentiment Signal: Sell
Current Market Cap: Yen5.69B
For detailed information about 4883 stock, go to TipRanks’ Stock Analysis page.